이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

만성 뇌졸중 환자의 뼈 대사에 대한 HIIT의 영향

2026년 9월 17일 업데이트: The Hong Kong Polytechnic University

만성 뇌졸중 환자의 뼈 대사에 대한 고강도 간격 훈련의 효과: 개념 증명, 무작위 대조 시험

Objectives: To investigate the effects of high-intensity interval training (HIIT) on musculoskeletal fitness in chronic stroke survivors.

Hypothesis to be tested: HIIT, performed on a recumbent stepper, will significantly enhance muscle power in chronic stroke survivors when compared with moderate-intensity continuous training (MICT) Design and subjects: Assessor-blinded, stratified, randomised, placebo-controlled clinical trial involving eligible 66 chronic stroke survivors.

Interventions: Participants will be randomly allocated to one of three groups: the HIIT group, the MICT group, or a stretching group (active control). Each group will attend sessions three times per week for 12 consecutive weeks, totaling 36 training sessions.

Main outcome measures: Assessments will be conducted at baseline, at mid-term of the intervention (week 6), at the end of the intervention (week 12), and at a 12-week follow-up (week 24). The primary outcome measure will be muscle power. Secondary outcome measures will include muscle strength, body composition, biomarkers, motor function, balance function, cardiorespiratory response, and psychosocial response.

연구 개요

상태

모병

정황

개입 / 치료

연구 유형

중재적

등록 (추정된)

66

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

연구 장소

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

50년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion criteria:

  • Men and postmenopausal women aged 50-80 years
  • 1-5 years following the first-ever stroke confirmed by magnetic resonance imaging or computed tomography
  • Able to walk 10 meters independently with or without a walking aid
  • Class I or II according to the New York Heart Association Functional Classification (no limitation or slight limitation of physical activity due to symptoms during ordinary physical activity)

Exclusion criteria:

  • Presence of other neurological comorbidities, significant liver or renal diseases, thyroid or parathyroid diseases, rheumatoid arthritis, or a fracture within the past 6 months
  • Undergoing osteoporosis treatments within the past 3 years, use of oral corticosteroids for more than 3 months within the past year, or botulinum toxin injections in the paretic lower limb within the past 6 months
  • Participation in ongoing stroke rehabilitation services or structured exercise programme
  • Cognitive or communication issues that could limit the ability to follow instructions
  • Contraindications to HIIT, graded exercise testing, or failure to pass medical clearance from a specialist

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: High-intensity interval training

The HIIT session will consist of a 3-minute warm-up, a 20-minute main exercise, and a 2-minute cool-down. The main exercise for HIIT will include ten high-intensity intervals, interspersed with ten low-intensity intervals.

There will be three sessions per week for 12 consecutive weeks, totaling 36 training sessions.

활성 비교기: Moderate-intensity continuous training

The MICT session will consist of a 3-minute warm-up, a main exercise that approximately matches the total workload of the HIIT session (lasting about 30 minutes), and a 2-minute cool-down. The intensity during the main exercise for MICT will remain below the vigorous level by progressively adjusting the workload throughout the intervention period.

There will be three sessions per week for 12 consecutive weeks, totaling 36 training sessions.

활성 비교기: Stretching

The stretching group will receive 25 minutes of whole-body stretching.

There will be three sessions per week for 12 consecutive weeks, totaling 36 training sessions.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Change from Baseline in Muscle Power at Week 12
기간: Baseline and Week 12

Muscle power (watt) of knee extensors on both the paretic and nonparetic sides will be measured using the isokinetic dynamometer.

Change=(Week 12 Level - Baseline Level)

Baseline and Week 12

2차 결과 측정

결과 측정
측정값 설명
기간
Change from Baseline in Muscle Power at Week 24
기간: Baseline and Week 24

Muscle power (watt) of knee extensors on both the paretic and nonparetic sides will be measured using the isokinetic dynamometer. Change=(Week 24 Level - Baseline Level)

Baseline and Week 24
Change from Baseline in Muscle Strength (Nm) at Week 12
기간: Baseline and Week 12

Muscle strength (Nm) of knee extensors on both the paretic and nonparetic sides will be measured using the isokinetic dynamometer.

Change=(Week 12 Level - Baseline Level)

Baseline and Week 12
Change from Baseline in Muscle Strength (Nm) at Week 24
기간: Baseline and Week 24

Muscle strength (Nm) of knee extensors on both the paretic and nonparetic sides will be measured using the isokinetic dynamometer.

Change=(Week 24 Level - Baseline Level)

Baseline and Week 24
Change from Baseline in Muscle Strength (kg) at Week 12
기간: Baseline and Week 12

Handgrip strength (kg) on both sides will be measured using a handheld dynamometer.

Change=(Week 12 Level - Baseline Level)

Baseline and Week 12
Change from Baseline in Muscle Strength (kg) at Week 24
기간: Baseline and Week 24

Handgrip strength (kg) on both sides will be measured using a handheld dynamometer.

Change=(Week 24 Level - Baseline Level)

Baseline and Week 24
Change from Baseline in Body Composition (kg) at Week 12
기간: Baseline and Week 12

Whole-body skeletal muscle mass (kg), bone mineral content (kg), fat mass (kg), and segmental lean mass (kg) will be measured using bioelectrical impedance analysis (BIA).

Change=(Week 12 Level - Baseline Level)

Baseline and Week 12
Change from Baseline in Body Composition (kg) at Week 24
기간: Baseline and Week 24

Whole-body skeletal muscle mass (kg), bone mineral content (kg), fat mass (kg), and segmental lean mass (kg) will be measured using bioelectrical impedance analysis (BIA).

Change=(Week 24 Level - Baseline Level)

Baseline and Week 24
Change from Baseline in Body Composition (%) at Week 12
기간: Baseline and Week 12

Body fat percentage (%) will be measured using bioelectrical impedance analysis (BIA).

Change=(Week 12 Level - Baseline Level)

Baseline and Week 12
Change from Baseline in Body Composition (%) at Week 24
기간: Baseline and Week 24

Body fat percentage (%) will be measured using bioelectrical impedance analysis (BIA).

Change=(Week 24 Level - Baseline Level)

Baseline and Week 24
Change from Baseline in Biomarkers at Week 12
기간: Baseline and Week 12

Volume-corrected serum concentration (mg/dL) of myokines, bone markers, pro-inflammatory markers, biomarkers of oxidative stress will be measured using enzyme-linked immunosorbent assay (ELISA) kits.

Change=(Week 12 Level - Baseline Level)

Baseline and Week 12
Change from Baseline in Biomarkers at Week 6
기간: Baseline and Week 6

Volume-corrected serum concentration (mg/dL) of myokines, bone markers, pro-inflammatory markers, biomarkers of oxidative stress will be measured using enzyme-linked immunosorbent assay (ELISA) kits.

Change=(Week 6 Level - Baseline Level)

Baseline and Week 6
Change from Baseline in Motor Function at Week 12
기간: Baseline and Week 12

Fugl-Meyer Motor Assessment (FMA) will be used to assess the degree of motor recovery of the hemiparetic upper (range: 0-66) and lower limbs (range: 0-34). Higher scores are indicative of better motor recovery. Short Physical Performance Battery (SPPB) will be used to assess the physical performance, including 5-times sit-to-stand, balance tests (side-by-side-stand, semi-tandem stand, and tandem stand), and gait speed.

Change=(Week 12 Score- Baseline Score)

Baseline and Week 12
Change from Baseline in Motor Function at Week 24
기간: Baseline and Week 24

Fugl-Meyer Motor Assessment (FMA) will be used to assess the degree of motor recovery of the hemiparetic upper (range: 0-66) and lower limbs (range: 0-34). Higher scores are indicative of better motor recovery. Short Physical Performance Battery (SPPB) will be used to assess the physical performance, including 5-times sit-to-stand, balance tests (side-by-side-stand, semi-tandem stand, and tandem stand), and gait speed.

Change=(Week 24 Score- Baseline Score)

Baseline and Week 24
Change from Baseline in Motor Function (meters) at Week 12
기간: Baseline and Week 12

The 6-minute walk test (6MWT) will be used to measure walking endurance and capacity. The total distance walked in meters during the test will be recorded.

Change=(Week 12 distance - Baseline distance)

Baseline and Week 12
Change from Baseline in Motor Function (meters) at Week 24
기간: Baseline and Week 24

The 6-minute walk test (6MWT) will be used to measure walking endurance and capacity. The total distance walked in meters during the test will be recorded.

Change=(Week 24 distance - Baseline distance)

Baseline and Week 24
Change from Baseline in Balance Function at Week 12
기간: Baseline and Week 12

Balance performance will be assessed using the Mini Balance Evaluation Systems Test (range: 0-28). Higher scores are indicative of better balance performance. Fear of falling will be assessed using the Chinese version of the Activities-Specific Balance Confidence Scale (range: 0-100). Higher scores are indicative of higher balance confidence.

Change=(Week 12 Score- Baseline Score)

Baseline and Week 12
Change from Baseline in Balance Function at Week 24
기간: Baseline and Week 24

Balance performance will be assessed using the Mini Balance Evaluation Systems Test (range: 0-28). Higher scores are indicative of better balance performance. Fear of falling will be assessed using the Chinese version of the Activities-Specific Balance Confidence Scale (range: 0-100). Higher scores are indicative of higher balance confidence.

Change=(Week 24 Score- Baseline Score)

Baseline and Week 24
Change from Baseline in Cardiopulmonary Response at Week 12
기간: Baseline and Week 12

Peak oxygen uptake (VO2peak) will be measured using a graded exercise test (GXT). The GXT will be conducted following a well-validated protocol that on a whole-body recumbent stepper to assess cardiopulmonary function in stroke patients.

Change=(Week 12 VO2peak - Baseline VO2peak)

Baseline and Week 12
Change from Baseline in Cardiopulmonary Response at Week 24
기간: Baseline and Week 24

Peak oxygen uptake (VO2peak) will be measured using a graded exercise test (GXT). The GXT will be conducted following a well-validated protocol that on a whole-body recumbent stepper to assess cardiopulmonary function in stroke patients.

Change=(Week 24 VO2peak - Baseline VO2peak)

Baseline and Week 24
Change from Baseline in Psychosocial Responses at Week 12
기간: Baseline and Week 12

Post-stroke fatigue will be assessed using the Fatigue Severity Scale (range: 1-7). Higher scores are indicative of more severe fatigue.

Health-related quality of life will be assessed using 12-Item Short Form Health Survey (range: 0-100). Higher scores are indicative of better quality of life.

Exercise enjoyment will be assessed by the Physical Activity Enjoyment Scale and Behavioural Regulation Exercise Questionnaire-3 (range: 0-400). Higher scores indicate a higher exercise enjoyment level.

Motivation for exercise will be assessed using the Behavioural Regulation Exercise Questionnaire-3 (range: 0-96). Higher scores indicate more motivation to exercise. A semi-structured interview will be additionally conducted at the end of the intervention (week 12) to explore the experiences of HIIT in stroke patients.

Change=(Week 12 Score - Baseline Score)

Baseline and Week 12
Change from Baseline in Psychosocial Responses at Week 24
기간: Baseline and Week 24

Post-stroke fatigue will be assessed using the Fatigue Severity Scale (range: 1-7). Higher scores are indicative of more severe fatigue.

Health-related quality of life will be assessed using 12-Item Short Form Health Survey (range: 0-100). Higher scores are indicative of better quality of life.

Exercise enjoyment will be assessed by the Physical Activity Enjoyment Scale and Behavioural Regulation Exercise Questionnaire-3 (range: 0-400). Higher scores indicate a higher exercise enjoyment level.

Motivation for exercise will be assessed using the Behavioural Regulation Exercise Questionnaire-3 (range: 0-96). Higher scores indicate more motivation to exercise. A semi-structured interview will be additionally conducted at the end of the intervention (week 12) to explore the experiences of HIIT in stroke patients.

Change=(Week 24 Score - Baseline Score)

Baseline and Week 24

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2024년 8월 20일

기본 완료 (추정된)

2027년 8월 5일

연구 완료 (추정된)

2027년 8월 5일

연구 등록 날짜

최초 제출

2024년 7월 30일

QC 기준을 충족하는 최초 제출

2024년 8월 14일

처음 게시됨 (실제)

2024년 8월 15일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 21일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 17일

마지막으로 확인됨

2025년 9월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • HSEARS20230720002

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .